Niki BioSolutions, Inc. (NIKI)
NASDAQ: NIKI · Real-Time Price · USD
9.49
+0.66 (7.47%)
Jul 21, 2026, 3:09 PM EDT - Market open
Niki BioSolutions Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1.36 | -4.27 | -2.82 | -9.8 | -25.05 |
Depreciation & Amortization | - | 0.26 | 1.13 | 1.21 | 1.19 |
Loss (Gain) From Sale of Assets | - | -0.06 | 0.11 | 0.21 | -0.07 |
Asset Writedown & Restructuring Costs | - | 1.7 | 0.75 | - | - |
Loss (Gain) From Sale of Investments | - | 1 | -6.34 | -5.45 | 8.03 |
Stock-Based Compensation | - | - | 1.27 | 1.65 | 1.68 |
Provision & Write-off of Bad Debts | - | 0.01 | 0.52 | - | - |
Other Operating Activities | -0.37 | 0.39 | -2.79 | -1.52 | -1.46 |
Change in Accounts Receivable | - | 0.04 | 0.13 | -0.1 | -0.02 |
Change in Inventory | - | - | 0.01 | 0.01 | 0 |
Change in Accounts Payable | -0.03 | -0.42 | 0.4 | 1.92 | 0.86 |
Change in Other Net Operating Assets | -0.07 | 0.17 | -0.08 | -0.43 | 0.18 |
Operating Cash Flow | -1.84 | -1.19 | -7.72 | -12.32 | -14.65 |
Capital Expenditures | - | - | -0 | -0.19 | -0.13 |
Sale of Property, Plant & Equipment | - | 0.06 | 0.02 | - | - |
Divestitures | - | - | - | - | -0.11 |
Sale (Purchase) of Intangibles | - | - | - | - | -0.01 |
Investment in Securities | - | - | 0.09 | - | 20.12 |
Other Investing Activities | - | - | 0.52 | 2.63 | -3.36 |
Investing Cash Flow | - | 0.06 | 0.62 | 2.44 | 16.51 |
Short-Term Debt Issued | - | - | 3 | 6 | - |
Long-Term Debt Issued | - | - | 2.5 | 0.5 | 3.5 |
Total Debt Issued | - | - | 5.5 | 6.5 | 3.5 |
Long-Term Debt Repaid | - | - | -3 | -0.05 | -5.54 |
Total Debt Repaid | - | - | -3 | -0.05 | -5.54 |
Net Debt Issued (Repaid) | - | - | 2.5 | 6.45 | -2.04 |
Issuance of Common Stock | 5.07 | - | 1.59 | 0.17 | 4.82 |
Other Financing Activities | -0.65 | - | - | 0.01 | - |
Financing Cash Flow | 4.42 | - | 4.09 | 6.63 | 2.78 |
Net Cash Flow | 2.58 | -1.13 | -3.01 | -3.25 | 4.64 |
Free Cash Flow | -1.84 | -1.19 | -7.73 | -12.51 | -14.78 |
Free Cash Flow Margin | - | - | -1791.32% | -965.04% | -958.85% |
Free Cash Flow Per Share | -2.50 | -2.18 | -17.09 | -35.04 | -42.20 |
Cash Interest Paid | - | - | 0.09 | 0.06 | 0.27 |
Levered Free Cash Flow | -1.1 | -1.96 | -3.61 | -7.04 | -11.07 |
Unlevered Free Cash Flow | -1.04 | -1.87 | -3.53 | -7.04 | -11.01 |
Change in Working Capital | -0.1 | -0.21 | 0.46 | 1.4 | 1.02 |